TRANSCRIPT
Q2 2022 — Fixed income management remarks
Q2 2022PDF · 5 pages83 KB
1 Barclays PLC H1 2022 Results Fixed Income Conference Call Q&A Transcript (amended in places to improve accuracy and readability) 28 July 2022 Lee Street, Citi Firstly, as it relates to the US shelf registration issue, do you presently face any impediments or restrictions in terms of either secondary market making or primary issuance across any currency or products? And then, as it relates to risk-weighted assets (RWAs), is there an upward bound of what you’d be comfortable hitting in the CIB as a share of overall Group RWAs? Secondly, do you split out the proportion of CIB RWAs that relate to [Global] Markets or can you give us any indication as to what they might be? Dan Fairclough, Group Treasurer On the first one in relation to the issuance programmes, we have the full set of programmes up and available to us, with the exception of the US structured notes programme, which we’re not currently issuing from given that we’ve announced the rescission offer. But all the other programmes are up and available to us, and there’s no further specific restrictions on our activities in relation to the capital markets. Anna Cross, Group Finance Director We don’t have a specific target for [CIB RWAs] or how we deploy RWAs around the Group. What you’re seeing is us essentially reacting to market opportunities, and we think that’s a really important part of being a diversified group. It would somewhat undermine that diversification if we had strict absolute limits. Having said that, some of the growth that you are seeing across H122 does relate to some of the regulatory changes that we had on the 1st January as opposed to business deployment. If you’re looking for the helpful disclosure around RWAs, we don’t split our Markets specifically. But if you look at page 61 of the RA, you can see the split of counterparty credit risk [and market risk] in Barclays International, so that might be helpful to you. Rob Smalley, UBS On slide 28 of the deck, you quite helpfully breakout UK versus US cards credit experience and coverage. There are some differences between UK and US cards in terms of impairment allowance development and where they stand [across] stage one, stage two and stage three. Investor Relations -- 1 of 5 -- 2 So my first question is, could you talk a little bit about that and what differences are you seeing in terms of consumer behaviour? [Secondly], could you also talk about German exposure - what are you seeing there? If the forecasts for the German economy pan out the way they are, particularly around energy issues, [are you] going to take a much bigger allowance there? Anna Cross, Group Finance Director There are quite big differences between the US cards and the UK cards businesses. The US cards business is a partner card business. It’s much younger in its derivation, if you like. We’re very focused on pursuing those partner programmes where we have strong relationships with the institutional clients, such as with GAP and JetBlue. Typically, what we see within that book is high FICO scores. It’s a very high quality credit book dominated by airline relationships, so we would see it as towards the premium end. We’ve onboarded GAP in the current quarter. GAP is a retail portfolio. They tend to be different in nature - smaller ticket items, normally a slightly different risk profile. But GAP as a book is very high quality - if you look at what happened to the FICO scores after that integration, you’ll see that it’s not really moved, which tells you how high quality it is. So that’s the US cards market. I guess what we’re seeing there is good purchase growth, but very high repayments and some balance growth. But in the US, I guess because the rewards programmes are very generous, we do see customers using their cards probably more so than we do in the UK. In the UK, cards balances have dropped sharply during COVID. That’s left us with a smaller book, but a book which is better in terms of its risk profile. The UK cards book, given our market share in the UK, is much more representative of the customer demographic as a whole. The reason that we’ve seen [balances] fall away is that because rewards programmes are simply not as generous [in the UK]. People tend to use the cards more as a borrowing mechanism rather than just a spending mechanism. Our spending behaviours changed through COVID, so we’ve seen those balances fall. You’ll see on both books fairly high levels of coverage. The one that I particularly look at is stage two coverage, so those are customers who we may have seen a degree of change in their behaviour. It may not be a concern for us if, for example, they start spending more on their cards. Your probability at default will go up just because you’re spending more. So we’re very focused on that cohort and you can see that the coverage levels on those two in particular are very high. 26% in the UK and 33% in the US. In terms of Germany, it’s a very mature portfolio. We feel that we have provided for it adequately. There are no concerning signs in the customer behaviour at this point in time. The story is not really any different to the UK or the US in terms of customer behaviour. So there’s nothing specifically I would call out, but I do recognise the deeper economic potential stress that there is in Germany, and therefore we’re very watchful. Dan David, Autonomous I’ve got three [questions]. The first one’s a bit more broad. Just looking at your CIB loan book, you’ve seen particularly strong growth. I’m just wondering if you can give us a bit of background and specific drivers of growth, certain sectors or geographies, just what might be making you stand out versus some of your peers? -- 2 of 5 -- 3 The other two are more focused on capital. With regards to your capital target of 13 to 14%, looking longer term, should we add the 1% CCYB to that? The reason why I ask is that the lower end of that looks quite skinny against the minimum requirement compared to peers. And then secondly, just focusing on AT1 in a bit more detail. Looking ahead to your calls next year, I think you’ve got another Sterling call coming up, is it right to assume that you’d look to [refinance that]? Would you stick to the currencies at which they’re issued? I hear your comments on the Tier 1 excess, could you reduce that Tier 1 headroom to facilitate a call if primary markets remain challenging in the short-term? Anna Cross, Group Finance Director I’ll take the first part of that question and then Dan will pick up from there. So there’s really two parts to the answer there. The first is £26bn up overall in wholesale lending - £14bn of that £26bn over the last six months relates to debt securities in the liquidity pool. So it’s just the way we present these things. It’s probably a little difficult to disentangle that, but we can help you do that in the disclosures. So of the £26bn there’s £14bn that’s essentially our own liquidity pool actions. The remaining balance is true client lending, I would say. That’s concentrated on IB clients. It’s investment grade clients drawing down on existing facilities. It’s not a massively significant number given the scale of our balance sheet overall, but we took that as a positive sign actually of positive economic activity, and given the quality of those clients, we didn’t have any concerns about it. Dan Fairclough, Group Treasurer In terms of the comments around the capital ratio, the 13 to 14% range was developed in contemplation of a normalisation of the [UK] CCYB, so we won’t be changing that range in respect of the CCYB announcements. Obviously, the MDA formulaically will go up to 11.9%, which is obviously in the slides. That would give us headroom of 110 to 210 basis points, which we’re comfortable with, and I’d probably reiterate two points that we made in the script. Firstly, we think that there is an element of stress buffers in that stack. In the event that there was a general market downturn, we would expect the Bank of England and the PRA to take action on the CCYB. Secondly, I would just highlight the capital generative nature of the franchise, and reiterate the capital generation from this quarter in terms of AP, and also the fact that a 10% RoTE is 150 basis points of capital generation. So we are comfortable with the stated capital target range. In terms of your comments on AT1, I don’t think you should link issuance to calls directly. There’s no particular need for us to refinance with Sterling. It is nice to have a component of Sterling of AT1 and particularly that’s helpful for BUK, but we definitely look at it on a portfolio basis rather than specific instrument-to-instrument matching. And yes, broadly you’re right, we could reduce the AT1 percentage if we needed to, and obviously that is one of the reasons why we run a buffer. We saw that play out this quarter given the FX movement. It did bring down that ratio as a result of the Dollar strength, so we wouldn’t be necessarily wedded to it but it’s broadly what we target. Anna Cross, Group Finance Director Thank you very much for attending the call and we’ll see you soon. Thank you. -- 3 of 5 -- 4 Important Notice The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. The information, statements and opinions contained in this presentation do not constitute a public offer under any applicable legislation, an offer to sell or solicitation of any offer to buy any securities or financial instruments, or any advice or recommendation with respect to such securities or other financial instruments. Information relating to: regulatory capital, leverage, liquidity and resolution is based on Barclays' interpretation of applicable rules and regulations as currently in force and implemented in the UK, including, but not limited to, CRD IV (as amended by CRD V applicable as at the reporting date) and CRR (as amended by CRR II applicable as at the reporting date) texts and any applicable delegated acts, implementing acts or technical standards and as such rules and regulations form part of UK law pursuant to the EU (Withdrawal) Act 2018 (as amended). On 31 March 2022, the temporary transitional powers (TTP) available to UK regulators to delay or phase-in on-shoring of EU legislation into UK law ended with full compliance of the on-shored regulations required from 1 April 2022. Following a consultation process in 2021 the PRA finalised their implementation of the CRR II package through Policy Statement 22/21. The finalised requirements were implemented in the UK through the PRA Rulebook with effect from 1 January 2022. All such regulatory requirements are subject to change and disclosures made by the Group will be subject to any resulting changes as at the applicable reporting date; MREL is based on Barclays' understanding of the Bank of England's policy statement on "The Bank of England's approach to setting a minimum requirement for own funds and eligible liabilities (MREL)" published in December 2021, updating the Bank of England's June 2018 policy statement, and its MREL requirements communicated to Barclays by the Bank of England. Binding future MREL requirements remain subject to change including at the conclusion of the transitional period, as determined by the Bank of England, taking into account a number of factors as described in the policy, along with international developments. The Pillar 2A requirement is also subject to at least annual review; future regulatory capital, liquidity, funding and/or MREL, including forward-looking illustrations, are provided for illustrative purposes only and are not forecasts of Barclays’ results of operations or capital position or otherwise. Illustrations regarding the capital flight path, end-state capital evolution and expectations and MREL build are based on certain assumptions applicable at the date of publication only which cannot be assured and are subject to change. Forward-looking Statements This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income levels, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of growth in banking and financial markets, projected expenditures, costs or savings, any commitments and targets (including, without limitation, environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations, group structure, IFRS impacts and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, the development of IFRS and other accounting standards, evolving practices with -- 4 of 5 -- 5 regard to the interpretation and application of accounting standards, emerging and developing ESG reporting standards, the outcome of current and future legal proceedings and regulatory investigations and any related impact on provisions, the policies and actions of governmental and regulatory authorities, the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, environmental, social and geopolitical risks and incidents or similar events beyond the Group’s control, and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; changes in valuation of credit market exposures; changes in valuation of issued securities; changes in credit ratings of any entity within the Group or any securities issued by such entities; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia- Ukraine War on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures or ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward- looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F, as amended, for the financial year ended 31 December 2021 and Barclays PLC’s Interim Results Announcement on Form 6-K, for the six months ended 30 June 2022), which are available on the SEC’s website at www.sec.gov. Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Non-IFRS Performance Measures Barclays management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Non-IFRS performance measures are defined and reconciliations are available on our results announcement for the period ended 30 June 2022. -- 5 of 5 --